Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1/2 2Phase 2/3 1

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1

Conditions

Breast Neoplasms 3498Neoplasms 2739Prostatic Neoplasms 1583Colorectal Neoplasms 1247Lung Neoplasms 1188Motor Activity 766Head and Neck Neoplasms 621Pancreatic Neoplasms 601Colonic Neoplasms 586Uterine Cervical Neoplasms 567Carcinoma, Non-Small-Cell Lung 560Carcinoma, Hepatocellular 558Rectal Neoplasms 516Stomach Neoplasms 493Brain Neoplasms 436Anxiety Disorders 401Ovarian Neoplasms 399Pain 376Esophageal Neoplasms 347Neoplasm Metastasis 340Polycystic Ovary Syndrome 339Fatigue 324Urinary Bladder Neoplasms 314Precursor Cell Lymphoblastic Leukemia-Lymphoma 303Melanoma 298Depression 286Multiple Myeloma 283Endometrial Neoplasms 263Lymphoma 258Hematologic Neoplasms 251

Interventions

Dipyrone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase NA × OTHER × Hemostatic Disorders × Clear all
NCT07384013 2026-02-03

Study Protocol: Impact of Metamizole (OptalginĀ®) on Anti-Xa Concentrations in Oncology Patients Receiving DOACs

Rambam Health Care Campus

Phase NA Recruiting
30 enrolled

Agnosia, Hemostatic Disorders

NCT03826043 2025-09-30

THEO

Centre Antoine Lacassagne

Phase NA Completed
700 enrolled

Neoplasms, Thrombosis, Hemostatic Disorders

NCT05634005 2025-03-06

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

University of Utah

Phase NA Completed
1,543 enrolled
Classical hematologyLymphoid

Afibrinogenemia, Anemia, Lymphoma, Follicular, Thrombocytopenia, Hemostatic Disorders

NCT03993977 2020-12-16

ROTEM-SUR

Tampere University Hospital

Phase NA Withdrawn

Neoplasms, Blood Loss, Surgical, Hemostatic Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚔